These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38588551)

  • 1. Essential considerations towards development of effective nasal antibiotic formulation: features, strategies, and future directions.
    Mardikasari SA; Katona G; Sipos B; Csóka I
    Expert Opin Drug Deliv; 2024 Apr; 21(4):611-625. PubMed ID: 38588551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of intranasally delivered peptides: key considerations for pharmaceutical development.
    Al Bakri W; Donovan MD; Cueto M; Wu Y; Orekie C; Yang Z
    Expert Opin Drug Deliv; 2018 Oct; 15(10):991-1005. PubMed ID: 30173579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced formulations for intranasal delivery of biologics.
    Rohrer J; Lupo N; Bernkop-Schnürch A
    Int J Pharm; 2018 Dec; 553(1-2):8-20. PubMed ID: 30316796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal route and drug delivery systems.
    Türker S; Onur E; Ozer Y
    Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
    Hu X; Yue X; Wu C; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
    Singh RM; Kumar A; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.
    Scherließ R
    Ther Deliv; 2020 Mar; 11(3):183-191. PubMed ID: 32046624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nose-to-brain delivery of antipsychotics using nanotechnology: a review.
    Tan MSA; Parekh HS; Pandey P; Siskind DJ; Falconer JR
    Expert Opin Drug Deliv; 2020 Jun; 17(6):839-853. PubMed ID: 32343186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical and physiological considerations for efficient nose-to-brain targeting.
    Bahadur S; Pathak K
    Expert Opin Drug Deliv; 2012 Jan; 9(1):19-31. PubMed ID: 22171740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
    Keller LA; Merkel O; Popp A
    Drug Deliv Transl Res; 2022 Apr; 12(4):735-757. PubMed ID: 33491126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal drug delivery: how, why and what for?
    Pires A; Fortuna A; Alves G; Falcão A
    J Pharm Pharm Sci; 2009; 12(3):288-311. PubMed ID: 20067706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing regional drug delivery within the nasal airways.
    Chen J; Finlay WH; Vehring R; Martin AR
    Expert Opin Drug Deliv; 2024 Apr; 21(4):537-551. PubMed ID: 38568159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal drug delivery in humans.
    Bitter C; Suter-Zimmermann K; Surber C
    Curr Probl Dermatol; 2011; 40():20-35. PubMed ID: 21325837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insoluble powder formulation as an effective nasal drug delivery system.
    Ishikawa F; Murano M; Hiraishi M; Yamaguchi T; Tamai I; Tsuji A
    Pharm Res; 2002 Aug; 19(8):1097-104. PubMed ID: 12240934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A consensus research agenda for optimising nasal drug delivery.
    Forbes B; Bommer R; Goole J; Hellfritzsch M; De Kruijf W; Lambert P; Caivano G; Regard A; Schiaretti F; Trenkel M; Vecellio L; Williams G; Sonvico F; Scherließ R
    Expert Opin Drug Deliv; 2020 Feb; 17(2):127-132. PubMed ID: 31928241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
    Galgatte UC; Kumbhar AB; Chaudhari PD
    Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of drug delivery to the brain via nasal route.
    Kozlovskaya L; Abou-Kaoud M; Stepensky D
    J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emulsion formulations of testosterone for nasal administration.
    Ko KT; Needham TE; Zia H
    J Microencapsul; 1998; 15(2):197-205. PubMed ID: 9532525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
    Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal route: an alternative approach for antiemetic drug delivery.
    Ozsoy Y; Güngör S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1439-53. PubMed ID: 22004793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.